Abstract
Classical galactosemia is detected through newborn screening by measuring galactose-1-phosphate uridylyltransferase (GALT) in the USA primarily via the Beutler spot assay. We report on an 18-month-old patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency that was originally diagnosed with classical galactosemia. The patient presented with elevated liver function enzymes and bilirubinemia and was immediately treated with soy-based formula. Confirmatory tests revealed deficiency of the GALT enzyme, however, full-sequencing of GALT was normal, suggestive of a different ideology. The Beutler spot assay uses three other enzymatic steps in addition to GALT. A deficiency in either of these enzymes can result in suspected decreased GALT activity when using the Beutler assay. Congenital Disorders of Glycosylation screening for phosphoglucomutase-1 deficiency was negative. Quantitative analysis of G6PD enzyme in red blood cells showed a severe deficiency and a deletion in G6PD. Soy-formula, the standard treatment for galactosemia, has been reported to trigger hemolysis in G6PD deficient patients. G6PD and phosphoglucomutase-1 deficiencies should be considered when confirmatory tests are negative for pathogenic variants in GALT and galactose-1-phosphate level is normal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 6PGD:
-
6-Phosphogluconate dehydrogenase
- ALT:
-
Alanine transaminase
- AST:
-
Aspartate aminotransferase
- CBC:
-
Complete blood count
- CDG:
-
Congenital disorders of glycosylation
- dl:
-
Deciliter
- G6PD:
-
Glucose-6-phosphate dehydrogenase
- Gal-1-P:
-
Galacose-1-phosphate
- GALT:
-
Galactose-1-phosphate uridylyltransferase
- Hb:
-
Hemoglobin
- hr:
-
Hour
- IU:
-
International unit
- μmol:
-
Micromole
- mg:
-
Milligram
- ml:
-
Milliliter
- NADP+ :
-
Nicotinamide adenine dinucleotide phosphate
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate
- NBS:
-
Newborn screening
- PGM1:
-
Phosphoglucomutase-1
- U/g:
-
Units per gram
- UDP-glucose:
-
Uridine diphosphate glucose
References
American College of Medical Genetics (2001) ACMG ACT sheets and confirmatory algorithms. Bethesda. http://www.ncbi.nlm.nih.gov/books/NBK55832/. Accessed 14 Nov 2016
Beutler E (1994) G6PD deficiency. Blood 84(11):3613–3636
Bosch AM (2006) Classical galactosaemia revisited. J Inherit Metab Dis 29(4):516–525
Caprari P, Caforio MP, Cianciulli P et al (2001) 6-Phosphogluconate dehydrogenase deficiency in an Italian family. Ann Hematol 80(1):41–44
Chevion M, Navok T, Glaser G, Mager J (1982) The chemistry of favism-inducing compounds. The properties of isouramil and divicine and their reaction with glutathione. Eur J Biochem 127(2):405–409
Frank JF, Maj MC (2005) Diagnosis and management of G6PD deficiency. Am Fam Physician 72(7):1277–1282
Frazier PDM, Summer GK (1974) Automated fluorometric micromethod for detection of transferase-deficiency galactosemia. J Lab Clin Med 83(2):334–338
Fujimoto A, Okano Y, Miyagi T, Isshiki G, Oura T (2000) Quantitative Beutler test for newborn mass screening of galactosemia using a fluorometric microplate reader. Clin Chem 46(6):806–810
Li Y, Ptolemy AS, Harmonay L, Kellogg M, Berry GT (2010) Quantification of galactose-1-phosphate uridyltransferase enzyme activity by liquid chromatography–tandem mass spectrometry. Clin Chem 56(5):772–780
Ohlsson A, Guthenberg C, von Döbeln U (2011) Galactosemia screening with low false-positive recall rate: the Swedish experience. JIMD Rep 2:113–117
Pyhtila BM, Shaw KA, Neumann SE, Fridovich-Keil JL (2014a) A brief overview of galactosemia newborn screening in the United States. J Inherit Metab Dis 37(4):649–650
Pyhtila BM, Shaw KA, Neumann SE, Fridovich-Keil JL (2014b) Newborn screening for galactosemia in the United States: looking back, looking around, and looking ahead. JIMD Rep 15:79–93
Scott K, Gadomski T, Kozicz T, Morava E (2014) Congenital disorders of glycosylation: new defects and still counting. J Inherit Metab Dis 37(4):609–617
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Daniela Karall
Appendices
Synopsis
Decreased GALT enzyme by Beutler spot assay can mask PGM1 or G6PD deficiencies and warrants further metabolic analysis in the absence of pathogenic variants in GALT. Soy-based formula intake can trigger hemolysis in G6PD deficiency.
Compliance with Ethics Guidelines
Conflict of Interest
Grace Stuhrman, Stefanie J. Perez Juanazo, Kea Crivelly, Jennifer Smith, Dr. Hans Andersson and Dr. Eva Morava declare that they have no conflicts of interest.
Informed Consent/Animal Rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). This article does not contain any studies with animal subjects performed by the any of the authors.
Details of the Contributions of Individual Authors
Grace Stuhrman drafted the initial manuscript and revised the manuscript.
Stefanie J. Perez Juanazo contributed to drafting the initial manuscript and conducted biochemical assays.
Jennifer Smith conducted biochemical assays.
Kea Crivelly, Eva Morava-Kozicz, and Hans Andersson critically reviewed and revised the manuscript.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Rights and permissions
Copyright information
© 2017 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stuhrman, G., Perez Juanazo, S.J., Crivelly, K., Smith, J., Andersson, H., Morava, E. (2017). False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 36. JIMD Reports, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2016_34
Download citation
DOI: https://doi.org/10.1007/8904_2016_34
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-56137-9
Online ISBN: 978-3-662-56138-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)